U-Chart Analysis:Shionogi & Co.,Ltd.:4507

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Shionogi & Co.,Ltd. Go to web site 4507 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Shionogi & Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Balance Sheet 2024年3月期 Shionogi & Co.,Ltd. Balance Sheet 2023年3月期 Shionogi & Co.,Ltd. Balance Sheet 2022年3月期 Shionogi & Co.,Ltd. Balance Sheet 2021年3月期 Shionogi & Co.,Ltd. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 358,090 309,224 254,420 276,173 208,861
Other Current AssetsHelp 426,115 474,968 404,785 280,065 307,165
Tangible Fixed AssetsHelp 124,026 118,567 112,417 95,710 76,007
Intangible Fixed AssetHelp 117,621 96,309 81,223 76,558 51,705
Investments and OthersHelp 375,779 302,913 288,118 261,129 222,103
Total AssetsHelp 1,416,918 1,311,800 1,150,601 998,992 873,695
Total Current LiabilitiesHelp 172,839 205,357 171,211 143,034 103,752
Total Long-term LiabilitiesHelp 8,753 6,397 3,729 9,850 4,791
Shareholder's EquityHelp 1,235,326 1,100,046 975,661 846,108 765,152
Total LiabilitiesHelp 1,416,918 1,311,800 1,150,601 998,992 873,695

Shionogi & Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Profit and Loss Account 2024年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2023年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2022年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2021年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 435,081 426,684 335,138 297,177 334,958
Total Sales 435,081 426,684 335,138 297,177 334,958
Cost of SalesHelp 57,602 62,246 55,415 52,523 56,782
Other Costs and RevenueHelp 215,449 179,473 165,538 132,795 155,981
Total CostsHelp 273,051 241,719 220,953 185,318 212,763
Net RevenueHelp 377,479 364,438 279,723 244,654 278,176
Earnings Before TaxHelp 198,283 220,332 126,268 143,018 158,516
Net IncomeHelp 162,030 184,965 114,185 111,859 122,195
Net Income 162,030 184,965 114,185 111,859 122,195

Shionogi & Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Cash Flow Statement 2024年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2023年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2022年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2021年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 154,285 177,866 102,068 109,039 131,940
Investing Cash Flow(ICF)Help 5,922 -48,292 -96,204 -5,261 -29,144
Financing Cash FlowHelp -126,853 -84,123 -36,615 -43,891 -88,174
Exchange Difference of Cash and Cash EquivalentsHelp 15,512 9,352 8,998 7,425 -1,560
Net Increase and Decrease in Cash and Cash Equivalentsn 48,866 54,803 -21,753 67,312 13,062

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Shionogi & Co.,Ltd.

Company where related level is highHelp

Modalis Therapeutics Corporation
MEDICAL & BIOLOGICAL LABORATORIES CO.
Toyama Chemical Co.,Ltd.
D.Western Therapeutics Institute, Inc.
JCR Pharmaceuticals Co.,Ltd.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
NIPPON CHEMIPHAR CO.,LTD.
Noile-Immune Biotech Inc.
Carna Biosciences,Inc.
RIBOMIC Inc.